Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens.

MLA

Tseng, Li-Hui, et al. “Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens.” American Journal of Clinical Pathology, vol. 152, no. 5, Nov. 2019, pp. 570–81. EBSCOhost, https://doi.org/10.1093/ajcp/aqz077.

APA

Tseng, L.-H., Marchi, F. D., Pallavajjalla, A., Rodriguez, E., Xian, R., Belchis, D., Gocke, C. D., Eshleman, J. R., Illei, P., Lin, M.-T., & De Marchi, F. (2019). Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens. American Journal of Clinical Pathology, 152(5), 570–581. https://doi.org/10.1093/ajcp/aqz077

Chicago

Tseng, Li-Hui, Federico De Marchi, Aparna Pallavajjalla, Erika Rodriguez, Rena Xian, Deborah Belchis, Christopher D Gocke, et al. 2019. “Clinical Validation of Discordant Trunk Driver Mutations in Paired Primary and Metastatic Lung Cancer Specimens.” American Journal of Clinical Pathology 152 (5): 570–81. doi:10.1093/ajcp/aqz077.